Andros

Andros

Digital platform for clinical trials management

Overview

Andros provides an integrated digital platform for life sciences and healthcare to streamline clinical trials and patient care. The platform collects real-time trial data, supports patient recruitment, and enables remote monitoring within a single ecosystem that can connect to existing systems while prioritizing security. It differentiates itself by offering end-to-end trial workflow tools with a focus on ease of use, seamless integration, and strict regulatory compliance, reducing administrative work compared with point solutions. The goal is to advance digital transformation in healthcare and clinical research by delivering practical tools that improve trial quality, efficiency, and patient outcomes.

Significant Headcount Growth

About Andros

Simplify's Rating
Why Andros is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Cybersecurity

Healthcare

Company Size

51-200

Company Stage

Late Stage VC

Total Funding

$58.4M

Headquarters

New York City, New York

Founded

2013

Get referred to Andros

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Medallion's acquisition gave Andros customers automated primary-source collection and real-time status tracking.
  • The combined platform now covers over one million providers across nearly 400 organizations.
  • AI agents handling outreach and follow-up reduce credentialing cycle times from weeks to days.

What critics are saying

  • Andros stopped as an independent employer after Medallion's September 15, 2026 acquisition.
  • Integration with Medallion risks customer churn during migration from Andros workflows and specialists.
  • Medallion now owns Andros; failure to integrate could erase Andros's standalone brand entirely.

What makes Andros unique

  • NCQA-certified CVO since 2013, Andros built trust with top health plans nationwide.
  • It processed 300,000 annual credentialing files across more than 200 provider networks.
  • Medallion bought Andros on September 15, 2026, for its provider-record relationships.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$58.4M

Below

Industry Average

Funded Over

7 Rounds

Late VC funding comparison data is currently unavailable. We're working to provide this information soon!
Late VC Funding Comparison
Coming Soon

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 4%

2 year growth

↑ 6%
PR Newswire
Sep 15th, 2026
Medallion acquires Andros to bring over 1M providers onto AI-native credentialing platform

Medallion has acquired Andros, an NCQA-certified credentials verification organisation, bringing over a million providers across nearly 400 healthcare organisations and health plans onto a single credentialing platform. The acquisition makes Medallion the largest AI-native credentialing platform in the US. Andros, which has credentialed providers for health plans, health systems, provider groups, and telehealth companies since 2013, will gain access to Medallion's AI-assisted features. These include automated primary source collection, AI agents for provider outreach, and real-time status tracking. Medallion will continue serving health plans, health systems, provider groups, digital health companies, and telehealth organisations. Bailey Company served as financial adviser to Andros. Transaction terms were not disclosed.

Recently Posted Jobs

Sign up to get curated job recommendations

Andros is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →